These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35027676)

  • 1. COVID-19 in HSCT recipients: a collaborative study of the Brazilian Society of Marrow Transplantation (SBTMO).
    Daudt LE; Corso MCM; Kerbauy MN; de Assis LHDS; Rechenmacher C; Colturato I; Barbieri FR; Rocha V; Mariano L; Garcia JL; Dantas VECB; Loth G; Funke VAM; Pelegrina PRD; Duarte FB; da Silva RL; Araújo MAS; Carlesse FAMC; de Sousa AVL; Maia LA; Fernandes JF; Rodrigues CA; Bonfim C; Martins LNGF; Cipolotti R; Xavier EM; Gomes AA; Morales HMP; Simioni AJ; Soares VJ; Michalowski MB; Hamerschlak N; Machado CM
    Bone Marrow Transplant; 2022 Mar; 57(3):453-459. PubMed ID: 35027676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
    Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
    Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
    Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes.
    Randi BA; Higashino HR; Silva VPD; Xavier EM; Rocha V; Costa SF
    Rev Med Virol; 2023 Nov; 33(6):e2483. PubMed ID: 37794598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
    Piñana JL; López-Corral L; Martino R; Montoro J; Vazquez L; Pérez A; Martin-Martin G; Facal-Malvar A; Ferrer E; Pascual MJ; Sanz-Linares G; Gago B; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; López-Jimenez J; Marcos-Corrales S; García-Blázquez M; Garcia-Gutiérrez V; Hernández-Rivas JÁ; Saus A; Espigado I; Alonso C; Hernani R; Solano C; Ferrer-Lores B; Guerreiro M; Ruiz-García M; Muñoz-Bellido JL; Navarro D; Cedillo A; Sureda A;
    Am J Hematol; 2022 Jan; 97(1):30-42. PubMed ID: 34695229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
    Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R;
    J Autoimmun; 2023 Apr; 136():103024. PubMed ID: 37001437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort.
    Gao H; Wang J; Zheng X; Pei X; Zheng Y; Zhai W; Zhang R; Chen X; Ma Q; Wei J; Yang D; Pang A; He Y; Feng S; Cao Y; Jiang E
    Front Cell Infect Microbiol; 2024; 14():1324019. PubMed ID: 38505288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation-A case report.
    Jarmoliński T; Matkowska-Kocjan A; Rosa M; Olejnik I; Gorczyńska E; Kałwak K; Ussowicz M
    Pediatr Transplant; 2021 Aug; 25(5):e13875. PubMed ID: 32949079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients.
    Lafarge A; Mabrouki A; Yvin E; Bredin S; Binois Y; Clere-Jehl R; Azoulay E
    Curr Opin Crit Care; 2022 Feb; 28(1):83-89. PubMed ID: 34813523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance and Outcomes of Pediatric Hematopoietic Stem Cell Transplantation Recipients During the Recent COVID-19 Outbreak in China.
    Wang X; Yu U; Ding C; Ye H; Wang C; Yang C; Li Y; Zhou X; Zhang Q; Liu S; Wen F
    Infect Drug Resist; 2023; 16():7455-7464. PubMed ID: 38089959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 in hematopoietic stem cell transplant recipients during three years of the pandemic: a multicenter study in Brazil.
    Randi BA; Higashino HR; Silva VPD; Salomão MC; Pignatari ACC; Abdala E; Vasques F; Silva CARD; Silva RLD; Lazari CDS; Levi JE; Xavier EM; Côrtes MF; Luna-Muschi A; Rocha V; Costa SF
    Rev Inst Med Trop Sao Paulo; 2024; 66():e17. PubMed ID: 38511806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.
    Jarisch A; Wiercinska E; Daqiq-Mirdad S; Hellstern H; Ajib S; Cremer A; Nguyen NTT; Dukat A; Ullrich E; Ciesek S; Chow KU; Serve H; Seifried E; Bader P; Bonig H; Bug G
    Eur J Immunol; 2022 Jul; 52(7):1194-1197. PubMed ID: 35389515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.
    Karataş A; Malkan ÜY; Velet M; Demiroğlu H; Büyükaşık Y; Telli Dizman G; Inkaya AÇ; Erdoğdu B; Çınar OE; Aladağ E; Aksu S; Haznedaroğlu İC; Özcebe O; Sayınalp N; Göker H
    Turk J Med Sci; 2021 Aug; 51(4):1647-1652. PubMed ID: 33878857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and HSCT (Hematopoietic stem cell transplant).
    Strasfeld L
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101399. PubMed ID: 36494150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [COVID-19 vaccination for allogeneic hematopoietic stem cell recipients].
    Nagafuji K
    Rinsho Ketsueki; 2022; 63(9):1067-1077. PubMed ID: 36198531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients.
    Wu X; Wang L; Shen L; He L; Tang K
    J Hematol Oncol; 2022 Jun; 15(1):81. PubMed ID: 35710431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study.
    Fan S; Mo X; Zhang X; Xu L; Wang Y; Yan C; Chen H; Zhang Y; Cheng Y; Sun Y; Chen Y; Chen Y; Han W; Wang J; Wang F; Xu Z; Huang X
    Ann Hematol; 2024 Apr; 103(4):1333-1344. PubMed ID: 38381172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
    Busca A; Salmanton-García J; Marchesi F; Farina F; Seval GC; Van Doesum J; De Jonge N; Bahr NC; Maertens J; Meletiadis J; Fracchiolla NS; Weinbergerová B; Verga L; Ráčil Z; Jiménez M; Glenthøj A; Blennow O; Tanase AD; Schönlein M; Prezioso L; Khanna N; Duarte RF; Žák P; Nucci M; Machado M; Kulasekararaj A; Espigado I; De Kort E; Ribera-Santa Susana JM; Marchetti M; Magliano G; Falces-Romero I; Ilhan O; Ammatuna E; Zompi S; Tsirigotis P; Antoniadou A; Zambrotta GPM; Nordlander A; Karlsson LK; Hanakova M; Dragonetti G; Cabirta A; Berg Venemyr C; Gräfe S; Van Praet J; Tragiannidis A; Petzer V; López-García A; Itri F; Groh A; Gavriilaki E; Dargenio M; Rahimli L; Cornely OA; Pagano L
    Front Immunol; 2023; 14():1125030. PubMed ID: 36911708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China.
    Gu ZY; Dong YJ; Fu XR; Li NN; Liu Y; Wu XX; Wang YN; Li YH; Ren HY; Zhang MZ; Li XF; Wang MH; Wu YM; Liu DH; Wang Z; Hu LD; Huang WR
    Chin Med J (Engl); 2021 Jun; 134(13):1584-1592. PubMed ID: 34133361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients.
    Leclerc M; Redjoul R; Le Bouter A; Beckerich F; Robin C; Parinet V; Pautas C; Menouche D; Bouledroua S; Roy L; Cabanne L; Nait-Sidenas Y; Fourati S; Maury S
    J Hematol Oncol; 2022 Mar; 15(1):27. PubMed ID: 35303906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.